Site #150, Stanford Cancer Center — Stanford, California

Site #150, Stanford Cancer Center is a clinical research site located in Stanford, California, United States 94305.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site #150, Stanford Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Adrenocortical Carcinoma.

Sponsors: Corcept Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Stanford

Browse all research sites in California · View every site in Stanford

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site #150, Stanford Cancer Center?

Site #150, Stanford Cancer Center has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site #150, Stanford Cancer Center conducted?

Site #150, Stanford Cancer Center has 1 clinical trials on record. Their work covers Adrenocortical Carcinoma.

Is Site #150, Stanford Cancer Center accredited by Crixeo Clinical Trials?

Site #150, Stanford Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site #150, Stanford Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.